UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. )*
BIODELIVERY SCIENCES INTERNATIONAL, INC.
(Name of Issuer)
Series A Non-Voting Convertible Preferred
(Title of Class of Securities)
| 09060J 10 6 (CUSIP Number) |
August 24, 2004
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)
| * | The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| 1. | Name of Reporting Person. S. S. or I.R.S. Identification No. of Reporting Persons
Andrew L. Finn |
|||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) ¨ |
|||
| 3. | SEC Use Only
|
|||
| 4. | Citizenship or Place of Organization
United States |
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5. Sole Voting Power
797,414 | |
| 6. Shared Voting Power
0 | ||
| 7. Sole Dispositive Power
797,414 | ||
| 8. Shared Dispositive Power
0 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
797,414 (Series A Non-Voting Preferred Stock convertible 1:1 for voting Common Stock) |
|||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ Not Applicable |
|||
| 11. | Percent of Class Represented by Amount in Row (9)
10.1% |
|||
| 12. | Type of Reporting Person (See Instructions)
IN |
| Item 1(a). | Name of Issuer |
BioDelivery Sciences International, Inc.
| Item 1(b). | Address of the Issuer’s Principal Executive Office |
185 South Orange Avenue, Admin. Building 4, Newark, New Jersey 07103
| Item 2(a). | Names of Persons Filing |
Andrew L. Finn
| Item 2(b). | Address of the Principal Business Office: |
531 Meadowmont Circle, Chapel Hill, North Carolina 27517
| Item 2(c). | Citizenship |
United States
| Item 2(d). | Title of Class of Securities |
Series A Non-Voting Convertible Preferred Stock
| Item 2(e). | Cusip Number |
09060J 10 6
| Item 3. | Filing Pursuant to Rules 13d-1(b) or 13d-2(b) |
Not Applicable
| Item 4. | Ownership |
| a. |
Amount Beneficially Owned: | 797,414 | ||
| b. |
Percent of class: | 10.1% | ||
| c. |
Number of shares as to which such person has: | |||
| i. Sole power to vote or to direct the vote: | 797,414 | |||
| ii. Shared power to vote or to direct the vote: | 0 | |||
| iii. Sole power to dispose or to direct the disposition of: | 797,414 | |||
| iv. Shared power to dispose or to direct the disposition of: | 0 | |||
| Item 5. | Ownership of Five Percent or Less of a Class |
Not Applicable
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person |
Not Applicable
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company |
Not Applicable
| Item 8. | Identification and Classification of Members of the Group |
Not Applicable
| Item 9. | Notice of Dissolution of Group |
Not Applicable
| Item 10. | Certification |
Not Applicable
After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.
Dated: September 1, 2004
| /s/ Jason S. Wood |
| Jason S. Wood, as attorney-in-fact for Andrew L. Finn |